comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 10:59:47 - browse：9

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： A new crop of companies is reshaping the health data economy

explore

WSS

Unmasking the 'centricity' illusion in clinical trials

U.S. death rates show how politics are affecting public health

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Roche’s Alnylam deal shows drug firms interested in heart drugs

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Achieving telehealth equity for people with hearing loss

focus

comprehensive

focus

In Memoriam: Notable people who died in 2023

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

In age of alternative facts, a scholarly course on calling out crap

U.S. death rates show how politics are affecting public health

BioMarin wins approval for gene therapy to treat hemophilia A

Why patients can’t get everything they want on drug pricing

Heart attack and stroke risk calculators need revising

What to watch for from Zogenix and Amicus clinical trials

Psychedelics group wrestles with new pharma identity

Why patients can’t get everything they want on drug pricing

leisure time

Rise in cancer among younger people worries and puzzles doctors

Dems pitch expanding Medicare power to negotiate drug prices

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Biden warns of ‘dark winter’ during final presidental debate

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Why some fertility treatments produce more boy babies

explore

explore

focus

Wikipedia